Macquarie Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-41,538
Closed -$13.5M – 2197
2024
Q1
$13.5M Sell
41,538
-96,899
-70% -$23.8M 0.02% 758
2023
Q4
$26.4M Sell
138,437
-81,416
-37% -$15.4M 0.03% 608
2023
Q3
$43.8M Sell
219,853
-43,239
-16% -$10.2M 0.06% 438
2023
Q2
$75.1M Sell
263,092
-208,291
-44% -$57.8M 0.09% 309
2023
Q1
$102M Sell
471,383
-284,625
-38% -$55.5M 0.12% 229
2022
Q4
$155M Sell
756,008
-208,801
-22% -$52.8M 0.18% 130
2022
Q3
$268M Sell
964,809
-152,328
-14% -$38.7M 0.33% 57
2022
Q2
$214M Buy
1,117,137
+232,570
+26% +$41.1M 0.24% 83
2022
Q1
$183M Buy
884,567
+343,144
+63% +$56.6M 0.14% 151
2021
Q4
$96.6M Buy
541,423
+45,553
+9% +$8.98M 0.08% 313
2021
Q3
$102M Sell
495,870
-130,152
-21% -$25.6M 0.09% 294
2021
Q2
$119M Sell
626,022
-18,476
-3% -$3.02M 0.1% 259
2021
Q1
$84M Sell
644,498
-39,760
-6% -$4.77M 0.12% 202
2020
Q4
$71M Buy
684,258
+116,410
+21% +$10.1M 0.1% 222
2020
Q3
$43M Buy
567,848
+10,447
+2% +$592K 0.07% 301
2020
Q2
$26.4M Buy
+557,401
New +$23M 0.05% 407

Other funds holding SWAV

Macquarie Group's SWAV Position: Q2 2024 in Review

Macquarie Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 41,538 shares — an estimated $13.5M sold.

Macquarie Group first reported a position in SWAV in Q2 2020 and held it in 16 quarters. The position peaked at $268M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Macquarie Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 41,538 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $13.5M.
  • Macquarie Group first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Macquarie Group's Shockwave Medical, Inc. Common Stock position peaked at $268M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.